Study of Radiotherapy and Pembrolizumab in People With Adrenocortical Carcinoma

NCT06066333 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

12

Enrollment

OTHER

Sponsor class

Conditions

Adrenocortical Carcinoma
ACC
Metastatic Adrenocortical Carcinoma

Interventions

RADIATION: Ablative Radiotherapy
DRUG: Pembrolizumab

Sponsor

Memorial Sloan Kettering Cancer Center